The threat of artemisinin resistant malaria in Southeast Asia

Travel Medicine and Infectious Disease

Volumn 14, Issue 6, 2016, Pages 548-550

  Hanboonkunupakarn, Borimas ^a   White, Nicholas J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Artemisinin resistance; Malaria

Indexed keywords

ARTEMISININ; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ANOPHELES GAMBIAE; ANTIMALARIAL DRUG RESISTANCE; CAMBODIA; CHEMOPROPHYLAXIS; CHINESE MEDICINE; DRUG TREATMENT FAILURE; EDITORIAL; HUMAN; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; SOUTHEAST ASIA; THAILAND; VIET NAM; DRUG EFFECTS; DRUG RESISTANCE; MALARIA, FALCIPARUM; PARASITOLOGY; PLASMODIUM; PLASMODIUM FALCIPARUM; TRAVEL;

ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; DRUG RESISTANCE; HUMANS; MALARIA; MALARIA, FALCIPARUM; PLASMODIUM; PLASMODIUM FALCIPARUM; TRAVEL;

EID: 85006135686     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2016.11.016     Document Type: Editorial

References (18)

1. [1] Wootton, J.C., Feng, X., Ferdig, M.T., Cooper, R.A., Mu, J., Baruch, D.I., et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418 (2002), 320–323.
2. [2] Roper, C., Pearce, R., Nair, S., Sharp, B., Nosten, F., Anderson, T., Intercontinental spread of pyrimethamine-resistant malaria. Science, 305(5687), 2004, 1124.
3. [3] World Health Organization, Guidelines for the treatment of malaria. third ed., 2015 Geneva.
4. [4] Noedl, H., Se, Y., Schaecher, K., Smith, B.L., Socheat, D., Fukuda, M.M., Artemisinin resistance in Cambodia 1 (ARC1) study consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 11:359 (2008), 2619–2620.
5. [5] Dondorp, A.M., Nosten, F., Yi, P., Das, D., Phyo, A.P., Tarning, J., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361 (2009), 455–467.
6. [6] Tun, K.M., Imwong, M., Lwin, K.M., Win, A.A., Hlaing, T.M., Hlaing, T., et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis 15 (2015), 415–421.
7. [7] Grist, E.P., Flegg, J.A., Humphreys, G., Mas, I.S., Anderson, T.J., Ashley, E.A., et al. Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia. Int J Health Geogr, 15, 2016, 37.
8. [8] Chenet, S.M., Akinyi Okoth, S., Huber, C.S., Chandrabose, J., Lucchi, N.W., Talundzic, E., et al. Independent emergence of the Plasmodium falciparum kelch propeller domain mutant allele C580Y in Guyana. J Infect Dis 213 (2016), 1472–1475.
9. [9] Ménard, D., Khim, N., Beghain, J., Adegnika, A.A., Shafiul-Alam, M., Amodu, O., et al. A Worldwide map of Plasmodium falciparum K13-Propeller polymorphisms. N Engl J Med 374 (2016), 2453–2464.
10. [10] Phyo, A.P., Ashley, E.A., Anderson, T.J., Bozdech, Z., Carrara, V.I., Sriprawat, K., et al. Declining efficacy of artemisinin combination therapy against P. Falciparum malaria on the Thai-Myanmar border (2003–2013): the role of parasite genetic factors. Clin Infect Dis 63 (2016), 784–791.
11. [11] Witkowski, B., Duru, V., Khim, N., Ross, L.S., Saintpierre, B., Beghain, J., et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis, 2016 Nov 3, 10.1016/S1473-3099(16)30415-7 pii: S1473-3099(16)30415-7. [Epub ahead of print].
12. [12] Amato, R., Lim, P., Miotto, O., Amaratunga, C., Dek, D., Pearson, R.D., et al. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis, 2016 Nov 3, 10.1016/S1473-3099(16)30409-1 pii: S1473-3099(16)30409-1. [Epub ahead of print].
13. [13] Woodrow, C.J., White, N.J., The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread. FEMS Microbiol Rev, 2016 Sep 8 pii: fuw037. [Epub ahead of print] Review.
14. [14] Ashley, E.A., Dhorda, M., Fairhurst, R.M., Amaratunga, C., Lim, P., Suon, S., et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371:5 (2014), 411–423.
15. [15] MalariaGEN Plasmodium falciparum Community Project, Genomic epidemiology of artemisinin resistant malaria. Elife, 5, 2016, e08714.
16. [16] St Laurent, B., Miller, B., Burton, T.A., Amaratunga, C., Men, S., Sovannaroth, S., et al. Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa. Nat Commun, 6, 2015, 8614.
17. [17] World Health Organization, Strategy for malaria elimination in the greater Mekong subregion (2015–2030). 2015 Geneva.
18. [18] United Nations World Tourism Orgnization, UNWTO tourism highlights, 2016 edition. 2016 Spain.